After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

R-Evolution Worldwide – Sierra Leone, a new local Community Based Organization

R-Evolution Worldwide – Sierra Leone is starting to operate in the Western Area Urban and Rural District of Freetown, Sierra Leone. R-Evolution Worldwide – Sierra Leone is local community-based organization, registered to

Read More

Second International Conference on Public Health in Africa

  The Second International Conference on Public Health in Africa (CPHIA) was held in Kigali on 13th-15th December 2022. In CPHIA 2022 conference were addressed discussion on need to ensure global health

Read More

African and European multidisciplinary researchers established an integrated consortium to develop a research project on the dengue and Zika viruses affecting Africa and the world

Dengue and Zika viruses are arboviruses primarily transmitted by Aedes mosquitoes. Dengue and Zika infectious disease frequently erupt in tropical and subtropical regions. Globalization coupled with climate change, significantly expedites their worldwide

Read More